RAPT Therapeutics, Inc. Operating Lease Liability
RAPT Therapeutics, Inc. had Operating Lease Liability of $4.49 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-03-06
- 2024-12-31: Operating Lease, Liability $4.49M.
- 2023-12-31: Operating Lease, Liability $6.91M.
- 2023-09-30: Operating Lease, Liability $7.46M.
- 2023-06-30: Operating Lease, Liability $8.00M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-12-31 | $4.49M 10-K · filed 2025-03-06 |
| 2023-12-31 | $6.91M 10-K · filed 2025-03-06 |
| 2023-09-30 | $7.46M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.00M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.53M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.99M 10-K · filed 2023-03-14 |
| 2022-09-30 | $7.87M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.22M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.59M 10-Q · filed 2022-05-11 |